Don't have Telegram yet? Try it now!
https://magazine.pharmamkt.net/2019/05/09/blaze-bioscience-announces-the-publication-of-phase-1-clinical-trial-results-for-tumor-paint-blz-100-tozuleristide-in-adults-with-glioma/
Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results for Tumor Paint: BLZ-100 (tozuleristide) in Adults with Glioma